Incidence and Risk Factors of Venous Thromboembolism in Patients Undergoing Surgery for Gynecologic Malignancies

0.068-0.933; p=0.039; OR: 0.002; 95% CI: 0.001-0.025; p=0.001; OR: 0.217; 95% CI: 0.082-0.577; p=0.002; OR: 0.033; 95% CI: 0.003-0.379; p=0.006, respectively]. Conclusion: We suggest that every patient undergoing gynecological oncology surgery should have preoperative pharmacological and postoperative extended dual prophylaxis to achieve the lowest incidence of VTE in this group.

[1]  Q. Tian,et al.  Risk factors of deep vein thrombosis of lower extremity in patients undergone gynecological laparoscopic surgery: what should we care , 2021, BMC Women's Health.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  A. Nathens,et al.  Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies , 2020, International Journal of Gynecological Cancer.

[4]  C. Flowers,et al.  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Barber,et al.  Prevention of venous thromboembolism in gynecologic oncology surgery. , 2017, Gynecologic oncology.

[6]  R. Burger,et al.  Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program , 2016, International Journal of Gynecologic Cancer.

[7]  B. Gage,et al.  Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery. , 2015, Gynecologic oncology.

[8]  W. Geerts,et al.  Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy? , 2014, Gynecologic oncology.

[9]  Michael K Gould,et al.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[10]  A. Weaver,et al.  Incidence and timing of venous thromboembolism after surgery for gynecological cancer. , 2011, Gynecologic oncology.

[11]  Caimiao Wei,et al.  Risk of Thromboembolic Disease in Patients Undergoing Laparoscopic Gynecologic Surgery , 2010, Obstetrics and gynecology.

[12]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[13]  G. del Priore,et al.  A comparison of thromboembolic prophylaxis in gynecologic oncology patients , 2001, International Journal of Gynecologic Cancer.